EFTA01522122.pdf

GHISLAINE MAXWELL- OAP FDG ACCT For the Period 12/1/I1 to 12/31/11 Equity Summary Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation US Large Cap Equity 149,066.00 160,064.44 10,976.44 97% Concentrated 8 Other Equity 6,135.38 0.00 (6,135.38) Total Value $155,221.38 $160,064.44 $4,843.08 97% Current Market Value/Cost Period Value Market Value 160.064.44 Tax Cost 146.020.49 Unrealized GainrLoss 14.043.95 Estimated Annual Income 536503 Accrued Dividends 239.79 Yield 3.36% Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 56.23 148.000 8,322.04 7,308.74 1,013.30 284.16 3.41% 002824-10-0 ABT ANALOG DEVICES INC 35.78 176.000 6,297.28 6,011.39 285.89 176.00 2.79% 032654-10-5 ADI AUTOMATIC DATA PROCESSING INC 54.01 150.000 8,101.50 7,264.05 837.45 237.00 2.93% 053015-10-3 ADP 59.25 J.P.Morgan Page 6 of 15 Confidential Treatment Requested by JPMorgan JPM-SDNY-00049603 Chase CONFIDENTIAL SDNY_GM_00318801 EFTA01522122